The groundbreaking research conducted by Van Andel Institute scientists sheds new light on how developmental epigenetic changes can profoundly influence cancer risk later in life. The study, published in Nature Cancer, identifies two distinct epigenetic states formed during development, which are
The NHS BRCA Testing Program launched in January 2023 has been a significant success in England, offering free genetic testing to individuals with Jewish ancestry to identify their risk of inherited cancers. This initiative targets people aged 18 or over with at least one Jewish grandparent, and it
In York, a family's journey of resilience and gratitude has culminated in a remarkable fundraising achievement for Cancer Research UK. The Burn family, inspired by their mother's successful battle against cancer, transformed their personal trials into a community-driven mission to support the
3D bioprinting is an innovative technology that promises to revolutionize cancer research and treatment by providing more accurate and complex models of tumor tissue. This advancement is particularly significant in the study of cancers involving the BRCA1 gene. Tumor modeling with 3D bioprinting
Researchers from the Stevens Institute of Technology have developed an advanced software tool named "clipping spline," which offers unprecedented capabilities for viewing and analyzing complex 3D biomedical images. This innovation enables deep and comprehensive visualization of optical coherence
Precision medicine represents an innovative approach to disease treatment and prevention that is biomarker-guided and individualized. It incorporates an individual's genetic information along with other social health determinants such as environment and lifestyle. This approach enables healthcare
